We also interrogated a real-world clinicogenomic database (CGDB) to assess prognostic implications for KRAS mutated subsets compared to other genomically defined cohorts of NSCLC, colorectal cancer (CRC), and pancreatic ductal adenocarcinoma (PDAC). The gene discussed is KRAS; the disease is non-small cell lung carcinoma.